Gene · 10460
Papers1,759
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,759
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Divergent microtubule-organizing center strategies in mammalian gametogenesis. | Trends Open | 2026 | 42761981 | PubTator, text mining | PubMed |
| FGFR2 fusion as the key to targeted therapy - a case report with a diagnostic turning point. | Klin Onkol | 2026 | 42663156 | PubTator, text mining | PubMed |
| Urinary proteomic signature of exercise intolerance in patients at risk of heart failure: evidence from the HOMAGE trial. | EBioMedicine | 2026 | 42531722 | PubTator, text mining | PubMed |
| TACC3, correlated with immune cell infiltrates, is a novel prognostic biomarker in BRCA. | Medicine (Baltimore) | 2026 | 42499031 | PubTator, text mining | PubMed |
| Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis. | Curr Pharm Des | 2026 | 42381324 | PubTator, text mining | PubMed |
| Identification of a novel PANoptosis-associated prognostic signature and immune landscape analysis in neuroblastoma with experimental validation. | Front Immunol | 2026 | 42273677 | PubTator, text mining | PubMed |
| A Multi-omics Investigation Identifies TACC3 as a Driver of Immunosuppression in Intrahepatic Cholangiocarcinoma via Activation of the STAT3-PD-L1 Axis. | J Clin Transl Hepatol | 2026 | 42181836 | PubTator, text mining | PubMed |
| The scaffold protein PRR14L is linked to mitotic fidelity and sensitivity to MPS1 inhibition. | Mol Biol Cell | 2026 | 42160513 | PubTator, text mining | PubMed |
| Development of an extended version of GALEAS bladder: Detection of FGFR3 fusions in urine and associations between genomic alterations and gene expression. | Bladder Cancer | 2026 | 42124891 | PubTator, text mining | PubMed |
| Nationwide genomic data analysis of central nervous system tumors in Japan based on C-CAT database. | Int J Clin Oncol | 2026 | 42089945 | PubTator, text mining | PubMed |
| FGFR alterations and potential role of FGFR inhibitors in pediatric brain tumors. | Neurooncol Adv | 2026 | 42058998 | PubTator, text mining | PubMed |
| Mechanistic design of cell-penetrating disruptors for phospho-dependent TACC3-CHC interaction. | Structure | 2026 | 42049022 | PubTator, text mining | PubMed |
| Context-dependent variability of HIF heterodimers influences interactions with macromolecular and small molecule partners. | Proc Natl Acad Sci U S A | 2026 | 42048441 | PubTator, text mining | PubMed |
| Molecular heterogeneity of HPV-associated cancers and strategies to overcome treatment resistance. | Cancer Heterog Plast | 2026 | 41938668 | PubTator, text mining | PubMed |
| Brachio-cervical inflammatory myopathy: multilevel clinical, histopathological and multi-omic analyses of a syndrome variably associated with systemic sclerosis. | Acta Neuropathol | 2026 | 41934478 | PubTator, text mining | PubMed |
| Coiled-coil centrosomal proteins facilitate tubulin concentration via polyKR motifs. | FEBS J | 2026 | 41934091 | PubTator, text mining | PubMed |
| ncRNA-Mediated Upregulation of AURKA Promotes Hepatocellular Carcinoma Progression and Alters the Immune Microenvironment. | Bioinform Biol Insights | 2026 | 41908244 | PubTator, text mining | PubMed |
| FGFR3-TACC3 fusion as a potential primary resistance mechanism to EGFR-TKI in lung adenocarcinoma harboring co-driven mutations: a case report. | Front Oncol | 2026 | 41907614 | PubTator, text mining | PubMed |
| Urine-Based Approaches for Screening, Diagnosis, and Surveillance of Urothelial Carcinoma. | J Pers Med | 2026 | 41893002 | PubTator, text mining | PubMed |
| From a Polymorphous Low-Grade Neuroepithelial Tumor to a Glioblastoma in an Adult Patient with FGFR3-TACC3 Fusion: A Case Report and Literature Review of the Molecular Profile. | Curr Oncol | 2026 | 41892193 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10460/papers